(Q44557879)

English

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

scientific article published in November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

author name string

Mohty M

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Jacot W

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Faucher C

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Bay JO

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Zandotti C

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Collet L

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Choufi B

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Bilger K

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Tournilhac O

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Vey N

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Stoppa AM

11

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Coso D

12

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Gastaut JA

13

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Viens P

14

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Maraninchi D

15

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Olive D

16

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Blaise D

17

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2168-2177

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403105

0 references

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

21 January 2018

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT). Infecti

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome after allogeneic bone marrow transplant for leukemia in older adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to tetanus toxoid immunization after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of graft versus host disease to high doses of methyl prednisolone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose bolus methylprednisolone for the treatment of acute graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403105

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403105

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44557879&oldid=2098879063"